Search details
1.
Interleukin-3 production by basal-like breast cancer cells is associated with poor prognosis.
Growth Factors
; : 1-13, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38299881
2.
Investigating the breast cancer screening-treatment-mortality pathway of women diagnosed with invasive breast cancer: Results from linked health data.
Eur J Cancer Care (Engl)
; 31(1): e13539, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34850484
3.
Three cases of BRAF-mutant melanoma with divergent differentiation masquerading as sarcoma.
Pathologica
; 114(3): 217-220, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35775707
4.
Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer.
Breast Cancer Res Treat
; 188(3): 729-737, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33751322
5.
Female breast cancer treatment and survival in South Australia: Results from linked health data.
Eur J Cancer Care (Engl)
; 30(5): e13451, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-33779005
6.
The impact of 2018 ASCO-CAP HER2 testing guidelines on breast cancer HER2 results. An audit of 2132 consecutive cases evaluated by immunohistochemistry and in situ hybridization.
Mod Pathol
; 33(9): 1783-1790, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32366941
7.
Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis.
Breast Cancer Res Treat
; 174(1): 165-177, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-30460464
8.
Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer.
BMC Health Serv Res
; 19(1): 387, 2019 Jun 14.
Article
in English
| MEDLINE | ID: mdl-31200700
9.
Molecular subtypes of screen-detected breast cancer.
Breast Cancer Res Treat
; 172(1): 191-199, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30046938
10.
Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may spare many women potentially unnecessary surgery, but at the risk of undertreatment for a minority: 10-year surgical outcomes of 114 consecutive cases from a single center.
Mod Pathol
; 31(3): 395-405, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29099502
11.
Contemporary indications for diagnostic open biopsy in women assessed for screen-detected breast lesions: A ten-year, single institution series of 814 consecutive cases.
Breast Cancer Res Treat
; 162(1): 49-58, 2017 02.
Article
in English
| MEDLINE | ID: mdl-28062979
12.
Phyllodes tumours of the breast: a consensus review.
Histopathology
; 68(1): 5-21, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26768026
13.
A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening.
Int J Cancer
; 136(6): 1411-21, 2015 Mar 15.
Article
in English
| MEDLINE | ID: mdl-25098753
14.
The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era.
Breast Cancer Res Treat
; 151(2): 347-55, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25904216
15.
Impact of hormone replacement therapy use on mammographic screening outcomes.
Cancer Causes Control
; 24(7): 1417-26, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23649232
16.
Silver In Situ Hybridization for the Rapid Assessment of MDM2 Amplification in Soft Tissue and Bone Tumors. Validation Based on an Audit of 192 Consecutive Cases Evaluated by Silver In Situ Hybridization and Fluorescence In Situ Hybridization.
Appl Immunohistochem Mol Morphol
; 31(2): 101-106, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36692149
17.
10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection.
Breast
; 70: 70-75, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37393644
18.
Looking beyond workforce parity: addressing gender inequity in pathology.
Pathology
; 55(6): 760-771, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37573162
19.
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program.
Breast Cancer Res Treat
; 134(2): 617-24, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22678156
20.
Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting.
Arch Pathol Lab Med
; 146(11): 1308-1318, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36270029